Caseware UK (AP4) 2022.0.179 2022.0.179 trueNo description of principal activity1true2022-07-011true 06611369 2022-07-01 2023-06-30 06611369 2021-07-01 2022-06-30 06611369 2023-06-30 06611369 2022-06-30 06611369 c:Director1 2022-07-01 2023-06-30 06611369 d:CurrentFinancialInstruments 2023-06-30 06611369 d:CurrentFinancialInstruments 2022-06-30 06611369 d:CurrentFinancialInstruments d:WithinOneYear 2023-06-30 06611369 d:CurrentFinancialInstruments d:WithinOneYear 2022-06-30 06611369 d:ShareCapital 2023-06-30 06611369 d:ShareCapital 2022-06-30 06611369 d:RetainedEarningsAccumulatedLosses 2023-06-30 06611369 d:RetainedEarningsAccumulatedLosses 2022-06-30 06611369 c:EntityHasNeverTraded 2022-07-01 2023-06-30 06611369 c:FRS102 2022-07-01 2023-06-30 06611369 c:AuditExemptWithAccountantsReport 2022-07-01 2023-06-30 06611369 c:FullAccounts 2022-07-01 2023-06-30 06611369 c:PrivateLimitedCompanyLtd 2022-07-01 2023-06-30 iso4217:GBP xbrli:pure

Registered number: 06611369










General & Medical Limited








Unaudited

Financial statements

Information for filing with the registrar

For the year ended 30 June 2023





 
General & Medical Limited
 

Contents



Page
Accountants' report
1
Balance sheet
2
Notes to the financial statements
3


 
General & Medical Limited
 
  
Chartered accountants' report to the director on the preparation of the unaudited statutory financial statements of General & Medical Limited for the year ended 30 June 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of General & Medical Limited for the year ended 30 June 2023 which comprise the Balance sheet and the related notes from the Company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW)we are subject to its ethical and other professional requirements which are detailed at https://www.icaew.com /regulation.

This report is made solely to the director of General & Medical Limited in accordance with the terms of our engagement letter dated 4 November 2021Our work has been undertaken solely to prepare for your approval the financial statements of General & Medical Limited  and state those matters that we have agreed to state to the director of General & Medical Limited in this report in accordance with ICAEW Technical Release TECH07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than General & Medical Limited and its director for our work or for this report. 

It is your duty to ensure that General & Medical Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and result of General & Medical Limited. You consider that General & Medical Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or review of the financial statements of General & Medical Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

  



Kreston Reeves LLP
Chartered Accountants
37 St Margaret's Street
Canterbury
Kent
CT1 2TU
2 November 2023
Page 1

 
General & Medical Limited
Registered number: 06611369

Balance sheet
As at 30 June 2023

2023
2022
£
£

  

Current assets
  

Cash at bank and in hand
  
4,563
3,963

  
4,563
3,963

Creditors: amounts falling due within one year
  
(4,580)
(3,980)

Net current liabilities
  
 
 
(17)
 
 
(17)

Total assets less current liabilities
  
(17)
(17)

  

Net liabilities
  
(17)
(17)


Capital and reserves
  

Called up share capital 
  
1
1

Profit and loss account
  
(18)
(18)

  
(17)
(17)


For the year ended 30 June 2023 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 1 November 2023.




Mr P S Ginsberg
Director

The notes on page 3 form part of these financial statements.

Page 2

 
General & Medical Limited
 

 
Notes to the financial statements
For the year ended 30 June 2023

1.


General information

General & Medical Limited is a limited liability company incorporated in England.  The company's registered office is 37 St Margaret's Street, Canterbury, Kent, CT1 2TU. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principle accounting policies have been applied:

 
2.2

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2022 - 1).




4.


Creditors: Amounts falling due within one year

2023
2022
£
£

Other creditors
4,580
3,980

4,580
3,980


Included in other creditors are amounts owing of £4,580 (2022: £3,980) to Insureon Group Ltd, a company under common control.

Page 3